Qualigen-Logo-Tag.png
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
September 20, 2024 09:00 ET | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced that on September 11, 2024, the Company received a notice from Nasdaq...
Logo_CheckPoint.png
Check Point Software is Recognized as a Leader in Email Security, Showcasing its Innovative AI-based Threat Intelligence Capabilities
September 20, 2024 09:00 ET | Check Point Software Technologies INC
Check Point named a Leader in Frost & Sullivan's Email Security report, celebrated for its innovative technology that provides advanced email protection.
ESGL 2024 Logo.png
ESGL Holdings Limited Reports First Half 2024 Financial Results
September 20, 2024 09:00 ET | ESGL Holdings Limited
ESGL HOLDINGS LIMITED REPORTS FIRST HALF 2024 FINANCIAL RESULTS WITH OPERATING SUBSIDIARY ACHIEVING FIRST PROFITABLE HALF YEAR
SEAL LOGO.png
SEALSQ Integrates Internet of Payment (IoP) in Next-Generation IoT-Enabled Semiconductors, Revolutionizing Connected Commerce
September 20, 2024 08:41 ET | SEALSQ
Geneva, Switzerland, Sept. 20, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum...
fortressbio1.jpg
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
September 20, 2024 08:30 ET | Fortress Biotech, Inc.
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to...
ATM logo.jpg
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
September 20, 2024 08:30 ET | Alpha Tau Medical Ltd.
JERUSALEM, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...
West Bancorporation logo
West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call
September 20, 2024 08:30 ET | West Bancorporation
WEST DES MOINES, Iowa, Sept. 20, 2024 (GLOBE NEWSWIRE) -- West Bancorporation, Inc. (Nasdaq: WTBA) (the “Company”), parent company of West Bank, will report its results for the third quarter of 2024...
logo.png
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum
September 20, 2024 08:30 ET | Autonomix Medical, Inc.
THE WOODLANDS, TX, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted...
logo-dark.png
Rezolve AI to Host Virtual Investor Update on September 26, 2024
September 20, 2024 08:30 ET | Rezolve AI Ltd
Rezolve AI aims to become a Leading AI Platform for Commerce in the Global eCommerce Market Rezolve Ai's foundational LLM - brainpowa – Levels-up Conversational Commerce Across 95 Languages Sets out...
M3-Brigade Acquisition V Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 23, 2024
September 20, 2024 08:30 ET | M3-Brigade Acquisition V Corp.
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- M3-Brigade Acquisition V Corp. (the “Company”) announced that, commencing on September 23, 2024, holders of the units sold in the Company’s initial...